Fylde and Wyre CCG Medicines Optimisation

Click each header to expand its content

Fylde and Wyre medicines RAG list

Application forms

Medicines commissioning policies

Actipatch for pain management 0.6 MB352
Albiglutide for type-2 diabetes mellitus 0.3 MB237
Alprostadil Cream For ED 0.3 MB271
Azelastine Fluticasone (Dymista) Nasal Spray 0.1 MB380
Bazedoxifene for oestrogen deficiency symptoms 0.3 MB226
Brimonidine For Erythema Of Rosacea 0.1 MB215
Brivaracetam for epilepsy 0.3 MB225
Budesonide multimatrix MMX 9mg prolonged release tablets 0.2 MB354
Certolizumab For Psoriatic Arthritis 0.1 MB187
Co-Proxamol For pain management 0.3 MB405
Co-trimoxazole for the prophylaxis of pneumocystis jirovecii (pneumocystis carinii) infections 0.3 MB247
Co-trimoxazole Prophylaxis of Primary and Secondary Spontaneous Bacterial Peritonitis (SBP) 0.1 MB313
Colesevelam (Cholestagel® ) For combination or monotherapy for familial hypercholesterolaemia 0.3 MB207
Colistimethate sodium/Colistin sulfomethate sodium (Colomycin® ) For non-Cystic Fibrosis in Patients with Bronchiectasis Colonised with Pseudomonas Aeruginosa 0.2 MB210
Conditions for which over the counter items should not routinely be prescribed in primary care 0.9 MB470
Daily selective serotonin re-uptake inhibitors (SSRIs) for the treatment of premature ejaculation (PE) 0.2 MB167
Dapoxetine for the treatment of premature ejaculation (PE) 0.2 MB170
Denosumab for GIO 0.2 MB171
Dulaglutide for the treatment of Type II Diabetes Mellitus in adults 0.3 MB269
Eflornithine-cream-for-facial-hirsutism 0.2 MB216
Eltrombopag For Thrombocytopenia In Hepatitis C 0.1 MB162
Eslicarbazepine For Focal Seizures 0.1 MB212
Evolocumab (Repatha SureClick® ) For prevention of cardiac events in patients with CHD and a history of ACS, in combination with a statin 0.1 MB190
Ferric Maltol 30mg Capsules in Adults for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease 0.3 MB189
Fluorouracil-5-cream-for-basal-cell-carcinomas 0.1 MB258
Guanfacine-for-ADHD 0.3 MB178
Imiquimod-5-cream-for-basal-cell-carcinomas 0.2 MB181
Insulin Degludec And Liraglutide 0.2 MB202
Insulin-Aspart-for-Diabetes-Mellitus 0.3 MB221
Insulin-Degludec-for-DM 0.3 MB194
Insulin-Detemir-for-DM 0.2 MB155
Insuline-Glargine-for-T1DM 0.3 MB177
Insuline-Glargine-for-T2DM 0.3 MB174
Invicorp-injection-for-erectile-dysfunction 0.3 MB340
Ivermectin-cream-for-rosacea 0.3 MB186
JIA Policy For Adults (Version 1.0) 0.2 MB180
Lamotrigine-for-trigeminal-neuralgia 0.3 MB188
Lamotrigine-for-trigeminal-neuralgia 2 0.3 MB198
Levonorgestrel 13.5mg IUD 0.3 MB162
Lidocaine Plasters For PHN 0.2 MB189
Lidocaine-plasters-for-unlicensed-indications 0.3 MB268
Liothyronine-for-refractory-hypothyroidism 0.2 MB235
Liraglutide-for-obesity 0.3 MB192
Lisdexamfetamine-for-ADHD-in-adults 0.3 MB328
Lisdexamfetamine-for-ADHD-update 0.3 MB220
Lurasidone-for-Schizophrenia 0.3 MB230
Magnaspartate For Hypomagnesaemia 0.3 MB1044
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 0.2 MB167
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 2 0.2 MB149
Midazolam-Epistatus-for-seizures 0.2 MB339
Opicapone-for-Parkinsons-disease-v2 0.5 MB213
Ospemifene for VVA 0.2 MB429
Oxycodone-Naloxone-for-Restless-legs 0.3 MB192
Paravit-CF-for-dietary-management-of-patients-with-cystic-fibrosis 0.2 MB922
Patiromer-for-hyperkalaemia 0.3 MB189
Patiromer-for-hyperkalaemia 2 0.3 MB218
Phosphodiesterase Type-5 Inhibitors 0.2 MB182
Pitolisant-for-Narcolepsyv2 0.3 MB237
Policy On Brand Inhaler Prescribing 0.3 MB579
Probiotics And VSL 0.3 MB215
Relvar Ellipta for COPD and asthma in adults 63 KB175
Rituximab-for-AIHA 0.4 MB201
Rituximab-for-ITP 0.4 MB182
Safinamide-for-Parkinsons-disease 0.3 MB219
Second-generation-LA-antipsychotics 0.3 MB218
Secukinumab-for-Palmoplantar-psoriasis 0.3 MB178
Secukinumab-for-Palmoplantar-psoriasis 2 0.3 MB161
Semaglutide for type 2 DM 0.2 MB319
Silk Garments For Eczema And Dermatitis 0.2 MB175
Simbrinza for chronic open angle glaucoma 0.1 MB178
Sodium Oxybate for Narcolepsy with Cataplexy 0.3 MB249
Spironolactone For Acne 0.1 MB248
Subcutaneous Depot Medroxyprogesterone Acetate 0.1 MB185
Tadalafil daily 0.3 MB366
Tapentadol for neuropathic pain in non-palliative care 0.4 MB198
Tapentadol for non-specific pain 0.2 MB199
Testosterone For Female Sexual Dysfunction 0.1 MB217
Tiotropium For Asthma 0.2 MB165
Tocilizumab SC For RA 0.1 MB144
Trelegy inhaler for COPD 0.3 MB349
Trimbow inhaler for COPD 0.4 MB256
Trimbow-inhaler-for-COPD 0.4 MB6
Ulipristal acetate for uterine fibroids 0.5 MB183
Umeclidinium For COPD 0.2 MB188
Vedolizumab For Crohn's Disease 0.2 MB148
Vesomni For Benign Prostatic Hyperplasia 0.1 MB180
Vitamins (inc Renavit) For Dialysis 0.3 MB435
Waterproof Cast Cover Policy 0.1 MB560
Xonvea for nausea and vomiting in pregnancy 0.1 MB187

Medicines guidelines, information sheets, and shared care

Further medicines guidelines are available on Lancashire Medicines Management Group’s website.

Primary care rebate schemes

Primary care rebate schemes are contractual arrangements offered by pharmaceutical companies, or third party companies, which offer retrospective financial rebates to the CCG on GP prescribing expenditure for particular branded medicine(s). The availability of a scheme does not influence the inclusion of specific medicines in care pathways or formularies.

Current Primary Care Rebate Schemes in place:

  • Clenil Modulite (Beclometasone) – Started July 2019
  • Fencino (Fentanyl) – Started April 2016
  • Firmagon (Degarelix) – Started September 2016
  • Januvia (Sitagliptin) – Started September 2018
  • Lixiana (Edoxaban) – Started February 2018
  • Longtec (Oxycodone SR) – Started July 2019
  • Sereflo (Fluticasone / Salmeterol) – Started July 2019
  • Seretide (Fluticasone / Salmeterol) – Started April 2016
  • Xarelto (Rivaroxaban) – Started October 2019
  • Zoladex (Goserelin) – Started January 2019

Fact and advice sheets

Inhaler Techniques

Inhaler technique videos are available to view online.

Last updated on 18 December 2019 at 11:14 by Senior communications and engagement officer N